The effect of the calcium ionophore A23187 on the release and metabolism of [3H]arachidonic acid was examined in normal polymorphonuclear leukocytes and those obtained from patients with chronic granulomatous disease. The ionophore A23187 which stimulates oxidative metabolism in normal polymorphonuclear leukocytes was ineffective in increasing oxidative metabolism (chemiluminescence) in polymorphonuclear leukocytes from patients with chronic granulomatous disease. However, the ionophore A23187 stimulated the release of [3H]arachidonic acid from chronic granulomatous disease neutrophil phospholipids and stimulated its metabolism into hydroxyeicosatetraenoic acids and leukotrienes.
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Chronic granulomatous disease (CGD) is characterized by an increased susceptibility to bacterial infections especially in infants or young children (20, 25) . Morphological events associated with CGD have shown that polymorphonuclear leukocytes (PMNs, neutrophils) effectively phagocytize bacteria and fungi but fail to kill these microorganisms (14, 20, 23, 26) . Biochemical evidence indicates that this defect in the microbicidal activity of PMNs from patients with CGD has been linked to the absence of the "respiratory burst" associated with phagocytosis of the microorganisms by PMNs (19) .
Normal human PMNs undergo marked alterations in oxidative metabolism, collectively referred to as the respiratory burst (3, 15) , in response to a number of stimuli, including phagocytosis (4), concanavalin A (30), detergents (18), the tumor-promoting agent phorbol myristate acetate (17) , and the calcium ionophore A23187 (29, 31) . Evidence by Allen (1) indicates that PMN-generated chemiluminescence correlates well with the respiratory burst activity. The calcium ionophore A23187 has previously been shown to be a potent stimulator of PMN chemiluminescence (16) . The calcium ionophore A23187 has been shown also to mobilize calcium ions (11, 27) and to stimulate the release of radiolabeled arachidonic acid from human neutrophil phospholipids (33, 35, 36 PMNs were isolated from peripheral venous blood from normal healthy volunteers and from two patients with CGD as has been previously described (32) . These cells were suspended in Dulbecco phosphate-buffered saline (PBS) containing both calcium and magnesium ions. For the chemiluminescence experiments, the PBS contained glucose (100 mg/dl) since the cells appeared to be maintained for longer periods of time under these conditions. In these experiments, the cells were maintained in plastic tubes on ice and were diluted to 5 x 105/ml with PBS containing glucose at room temperature immediately before use. PMN chemiluminescence in a luminol-enhanced system was done as previously described (16) . For the lipid assays, the cells were suspended at 3.5 x 10 /ml in PBS without glucose. Neutrophils (3.5 There have been several proposed mechanisms for the release of arachidonic acid at least from platelet cellular phospholipids: a direct release by phospholipase A2 (8) or an indirect release by a phosphatidylinositol-specific phos- We thank Charles McCall, Carolyn Huntley, and Harry Gallis for providing cells from patients. We also thank Tommye Campbell for editorial assistance and typing.
